Analystreport

Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com